
02 Mar 2021
Hikma Pharmaceuticals (Hold) - Reducing forecasts and valuation for FY21E outlook
This content is only available within our institutional offering.

Sign in
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
Hikma Pharmaceuticals (Hold) - Reducing forecasts and valuation for FY21E outlook
Hikma Pharmaceuticals Plc (HIK:LON) | 1,720 -51.6 (-0.2%) | Mkt Cap: 3,816m
- Published:
02 Mar 2021 -
Author:
Miles Dixon | Amy Walker | Anchal Verma -
Pages:
13 -